Zhejiang Xingyue Biotechnology Co., Ltd.   Report issue

For profit Phase 2
Founded: Yongkang China (1989)

Organization Overview

First Clinical Trial
2017
NCT03300531
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Zhejiang Xingyue Biotechnology Co., Ltd.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Rotator Cuff Injuries (Phase 2)

Tendinopathy (Phase 2)

Tennis Elbow (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 3